Search results
Hims & Hers says it will offer GLP-1 weight-loss drugs, shares surge
Axios· 11 hours agoFlashback: Hims & Hers CEO Andrew Dudum told Axios in 2023 that the company viewed weight-loss drugs as an "exciting space" and that "it's not a question of will Hims & Hers ...
Sheryl Sandberg's film on Hamas' Oct. 7 on Israel attack to screen at Capitol
Axios· 29 minutes agoSheryl Sandberg spent four days in Israel filming interviews for a documentary about sexual violence...
Fed policymakers still cautious on inflation and policy
Reuters via Yahoo Finance· 22 hours ago(Reuters) -Federal Reserve officials are not ready to say inflation is heading to the central bank's...
One family's adoption story and how you can learn more
Axios· 23 hours agoIn a new People magazine article, Axios CEO Jim VandeHei and his wife, Autumn VandeHei, tell how...
ICC scores resounding rebuke from Democrats
Axios· 9 hours agoThe International Criminal Court's (ICC) decision to seek an arrest warrant against Israel Prime Minister Benjamin Netanyahu garnered near universal...
‘That is madness’: What Pope Francis said about closing the U.S. border, war on ‘60 Minutes’
Deseret News via Yahoo News· 14 hours agoHe said regardless of the end decision, each migrant should be treated “humanely” by the U.S. Texas...
Microsoft's new AI PCs have total recall
Axios· 7 hours agoDriving the news: A new Windows 11 feature, called Recall, took center stage at an event Monday, where Microsoft also introduced a new Copilot+ branding...
Biden says what's happening in Gaza is "not genocide" amid ICC's Netanyahu warrant request
Axios· 15 hours agoPresident Biden criticized the ICC's decision to seek arrest warrants for Israeli Prime Minister...
Perplexity: Why AI fundraising has become a rat race
Axios· 2 days agoAt Axios' BFD event on Tuesday, Perplexity CEO Aravind Srinivas dismissed recent rumors that the company is raising a large new funding round. There are...
Axios Vitals
Axios· 6 days agoHouse lawmakers today are expected to set in motion a massive reordering of how U.S. pharmaceuticals are developed and made, by advancing a contracting ban on five key Chinese research firms ...
